I am a
Home I AM A Search Login

Papers of the Week


Clin Cosmet Investig Dermatol


Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series.


Luo N, Wang Q, Lei M, Li T, Hao P
Clin Cosmet Investig Dermatol. 2022; 15:1863-1867.
PMID: 36117770.


Chronic prurigo (CPG) is a chronic inflammatory disease characterized by intense pruritus, and therapy is often challenging due to its unclear pathogenesis. Here, we report four patients with refractory CPG from different backgrounds who experienced failure of conventional therapy and were controlled with dupilumab, accompanied by a significant decrease in pruritus numerical rating scale, dermatology life quality index, and investigator global assessment, without adverse effects. Furthermore, dupilumab improved the condition of asthma in CPG patients along with an increase in asthma control test scores.